Lam Research Corporation
NASDAQ:LRCXSemiconductors
+$19.70 today
- Market cap
- $264.41B
- Beta
- 1.87
- P/E (TTM)
- 73.4
- EPS (TTM)
- $5.37
- Dividend yield
- 0.26%
Volume 7.61M
Average 11.84M
LRCX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Lam Research CorporationNASDAQ: LRCX
Common Stock · Q1 FY2027 · quarter ended Sep 2026
Common stock broadly unchanged from a year ago
Common stock stood at $1.25M at the end of Q1 FY2027, down 0.7% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at +111.1% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2027, unchanged from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
What to watch
Whether common stock keeps falling in the next quarterly balance sheet after a -0.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2026
- 1.25M USD
- Year-over-year change
- -1.3%
- 4-year CAGR
- +73.8%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-28 | 1.25M | -1.3% |
| FY2025 | 2025-06-29 | 1.27M | +875.4% |
| FY2024 | 2024-06-30 | 130K | -2.3% |
| FY2023 | 2023-06-25 | 133K | -2.9% |
| FY2022 | 2022-06-26 | 137K | — |
Common Stock vs competitors
How LRCX compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -0.7% is the 4th highest of 5, against a peer median of +0.7%.
- Common stock amounts to 0.0% of total assets for LRCX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.31M USD | +890.2% | +112.1% | 0.0% | |
| Sep 2026 | $1.25M USD | -0.7% | +111.1% | 0.0% | |
| Sep 2026 | $611K USD | +1.5% | +5.3% | 0.0% | |
| Sep 2026 | $7K USD | +0.0% | +5.3% | 0.0% | |
| Sep 2026 | €0 EUR | — | -1.3% | 0.0% | |
| Oct 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding LRCX) | — | +0.7% | +5.3% | 0.0% | |
Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.52B | 5.34B | 5.85B | 6.39B | 5.58B |
| Short-term Investments | 135.73M | 37.64M | 0 | 0 | 0 |
| Net Receivables | 4.31B | 2.82B | 2.52B | 3.38B | 5.34B |
| Inventory | 3.97B | 4.82B | 4.22B | 4.31B | 4.28B |
| Other Current Assets | 0 | (37.64M) | 298.19M | 440.27M | 0 |
| Total Current Assets | 12.29B | 13.23B | 12.88B | 14.52B | 15.61B |
| Property, Plant & Equipment (Net) | 1.65B | 1.86B | 2.15B | 2.43B | 2.96B |
| Goodwill | 1.52B | 1.62B | 1.63B | 1.63B | 1.63B |
| Intangible Assets | 101.85M | 168.45M | 138.55M | 182.2M | 269.3M |
| Long-term Investments | 0 | 0 | 2.95M | 17M | 18.77M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.65B | 1.91B | 1.94B | 2.57B | 3.05B |
| Total Non-current Assets | 4.91B | 5.55B | 5.86B | 6.83B | 7.92B |
| Total Assets | 17.2B | 18.78B | 18.74B | 21.35B | 23.53B |
| Account Payables | 1.01B | 470.7M | 613.97M | 854.21M | 1.3B |
| Short-term Debt | 0 | 421K | 501.32M | 749.67M | 94.49M |
| Tax Payables | 465.6M | 885.35M | 186.7M | 0 | 0 |
| Deferred Revenue | 1.57B | 1.7B | 1.42B | 2.57B | 2.28B |
| Other Current Liabilities | 1.3B | 1.32B | 1.35B | 1.48B | 977.02M |
| Total Current Liabilities | 4.56B | 4.18B | 4.34B | 6.57B | 5.94B |
| Long-term Debt | 4.96B | 4.96B | 4.47B | 3.72B | 3.72B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.35B | 1.38B | 1.39B | 991.68M | 1.09B |
| Total Non-current Liabilities | 6.35B | 6.39B | 5.87B | 4.92B | 5.12B |
| Total Liabilities | 10.92B | 10.57B | 10.21B | 11.48B | 11.06B |
| Common Stock | 137K | 133K | 130K | 1.27M | 1.25M |
| Retained Earnings | 18.45B | 22.03B | 24.81B | 28.99B | 34.95B |
| Accumulated OCI | (109.98M) | (100.71M) | (130.43M) | (62.42M) | (127.09M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 6.28B | 8.21B | 8.54B | 9.86B | 12.47B |
| Total Debt | 5.01B | 5.01B | 4.98B | 4.76B | 4.12B |
| Net Debt | 1.48B | (325.52M) | (864.52M) | (1.63B) | (1.46B) |
Lam Research Corporation
NASDAQ:LRCX
Intrinsic Alpha fair value
Locked
Current Price
$211.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.